NOT-CA-20-102: Notice of Extension of the Expiration Date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)"

Notice of Extension of the Expiration Date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)"

Notice Number:

NOT-CA-20-102

Key Dates

Release Date:

September 10, 2020

Related Announcements

PAR-18-365 - NCI Mentored Research Scientist Development Award to Promote Diversity (K01 - Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)" by one Application Due Date.

Therefore, with the addition/extension by one Application Due Date of February 12, 2021, PAR-18-365 will now expire on May 8, 2021.

The following sections in Part 1. Overview Information, Key Dates, have been changed:

Currently reads:

Application Due Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Currently reads:

Scientific Merit Review: Standard dates apply

Currently reads:

Advisory Council Review: Standard dates apply

Currently reads:

Earliest Start Date: Standard dates apply

Currently reads:

Expiration Date: January 8, 2021

Corrected to read (in italics):

Expiration Date: May 8, 2021

All other aspects of PAR-18-365 remain unchanged.

Inquiries

Please direct all inquiries to:

John O. Ojeifo, M.D., Ph.D., M.B.A.
National Cancer Institute (NCI)
Telephone: 240-276-6186
Email: [email protected]